Cargando…
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
INTRODUCTION: The introduction of targeted drugs has had a significant impact on the approach to assessing tumour response. These drugs often induce a rapid cytostatic effect associated with a less pronounced and slower tumoural volume reduction, thereby impairing the correlation between the absence...
Autores principales: | Woff, Erwin, Hendlisz, Alain, Garcia, Camilo, Deleporte, Amelie, Delaunoit, Thierry, Maréchal, Raphaël, Holbrechts, Stéphane, Van den Eynde, Marc, Demolin, Gauthier, Vierasu, Irina, Lhommel, Renaud, Gauthier, Namur, Guiot, Thomas, Ameye, Lieveke, Flamen, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969337/ https://www.ncbi.nlm.nih.gov/pubmed/27072811 http://dx.doi.org/10.1007/s00259-016-3365-x |
Ejemplares similares
-
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
por: Hendlisz, Alain, et al.
Publicado: (2015) -
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
por: Charette, Nicolas, et al.
Publicado: (2019) -
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
por: Vandeputte, Caroline, et al.
Publicado: (2018) -
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
por: Camera, Silvia, et al.
Publicado: (2020) -
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)